Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Aug 30;17(8):e0273834.
doi: 10.1371/journal.pone.0273834. eCollection 2022.

Tuberculosis-specific antigen stimulated and unstimulated interferon-γ for tuberculous meningitis diagnosis: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Tuberculosis-specific antigen stimulated and unstimulated interferon-γ for tuberculous meningitis diagnosis: A systematic review and meta-analysis

Fangyu Shi et al. PLoS One. .

Abstract

Objective: Tuberculous meningitis (TBM) is one of the most devastating TB. Accurate identification of TBM is helpful to eliminate TB. Therefore, we assessed the performance of TBAg stimulated IFN-γ (IGRA) and unstimulated IFN-γ in blood and cerebrospinal fluid (CSF) for diagnosing TBM.

Methods: We searched Web of Science, PubMed, Embase and the Cochrane Library databases until March 2022. Bivariate and hierarchical summary receiver operating characteristic models were employed to compute summary estimates for diagnostic accuracy parameters of IGRA and unstimulated IFN-γ in blood and CSF for diagnosing TBM.

Results: 28 studies including 1,978 participants and 2,641 samples met the inclusion criteria. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and area under the curve (AUROC) of blood IGRA were separately as 0.73, 0.83, 4.32, 0.33, 13.22 and 0.86, indicating a good diagnostic accuracy of blood IGRA for detecting TBM. The summary sensitivity, specificity, PLR, NLR, DOR and AUROC of CSF IGRA were separately as 0.77, 0.91, 8.82, 0.25, 34.59 and 0.93, indicating good diagnostic accuracy of CSF IGRA for detecting TBM. The summary sensitivity, specificity, PLR, NLR, DOR and AUROC of CSF IFN-γ were separately as 0.86, 0.92, 10.27, 0.16, 65.26 and 0.95, suggesting CSF IFN-γ provided excellent accuracy for diagnosing TBM.

Conclusions: For differentiating TBM from non-TBM individuals, blood and CSF IGRA are good assays and unstimulated CSF IFN-γ is an auxiliary excellent marker.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Articles’ selection process.
Fig 2
Fig 2. Quality for the included articles.
Fig 3
Fig 3. Hierarchical summary receiver operating characteristic (HSROC) plot to summarize diagnostic accuracy for blood IGRA in diagnosing tuberculous meningitis (blue curve).
Summary estimate of diagnostic accuracy is indicated by the red square.
Fig 4
Fig 4. Hierarchical summary receiver operating characteristic (HSROC) plot to summarize diagnostic accuracy for CSF IGRA in diagnosing tuberculous meningitis.
Fig 5
Fig 5. Hierarchical summary receiver operating characteristic (HSROC) plot to summarize diagnostic accuracy for unstimulated CSF IFN-γ in diagnosing tuberculous meningitis.

Similar articles

Cited by

References

    1. Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
    1. Seddon JA, Tugume L, Solomons R, Prasad K, Bahr NC, Tuberculous Meningitis International Research Consortium. Tuberculous Meningitis International Research Consortium. The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes. Wellcome Open Res. 2019; 4:167. doi: 10.12688/wellcomeopenres.15535.1 - DOI - PMC - PubMed
    1. Manyelo CM, Solomons RS, Walzl G, Chegou NN. Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches. J Clin Microbiol. 2021; 59: e01771–20. doi: 10.1128/JCM.01771-20 - DOI - PMC - PubMed
    1. Wilkinson RJ, Rohlwink U, Misra UK, Crevel RV, Mai NTH, Dooley KE, et al. Tuberculous meningitis. Nat Rev Neurol. 2017; 13:581–598. doi: 10.1038/nrneurol.2017.120 - DOI - PubMed
    1. Ahlawat S, Chaudhary R, Dangi M, Bala K, Singh M, Chhillar AK. Advances in tuberculous meningitis diagnosis. Expert Rev Mol Diagn. 2020; 20:1229–1241. doi: 10.1080/14737159.2020.1858805 - DOI - PubMed

Publication types